Market HighlightsMacrolides such as azithromycin, clarithromycin, and erythromycin are a class of antibiotics that inhibit protein synthesis.
It acts as a bacteriostatic agent against many strains of corynebacteria, listeria, moxicella, streptococci, Neisseria meningitides, Staphylococci, Clostridia, and Haemophilus sp.
It is used for the treatment of bacterial infections, such as nose, ear, and throat infections, chest infections, skin infections as well as mouth and dental infections.
They are also used as an alternative to penicillin.The global macrolide antibiotics market is expected to show a sharp growth over the forecast period owing to an increasing demand for macrolide across the globe.
Rising prevalence of bacterial skin infections and rising number of dermatology clinics also favor the market growth.
According to a study published in the Journal of the American College of Cardiology, macrolide antibiotics may increase the risk of sudden cardiac death, ventricular tachyarrhythmias, and cardiovascular death in patients, which may hinder the growth of the market over the assessment period.Request For Sample Report:Â https://www.marketresearchfuture.com/sample_request/4342Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.However, concerns over the adverse effects of macrolide antibiotics such as the gastrointestinal disturbances and adverse hepatic metabolism.
Macrolide antibiotics are also reported to worsen cardiac functioning resulting in tachyarrhythmias, and even death in patients, which is hampering the market growth.Global Macrolide Antibiotics Market – SegmentsThe report is segmented into five dynamics to widen the scope of understanding,By Drugs : Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, And Telithromycin among others.By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023 Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.
By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.However, concerns over the adverse effects of macrolide antibiotics such as the gastrointestinal disturbances and adverse hepatic metabolism.
Macrolide antibiotics are also reported to worsen cardiac functioning resulting in tachyarrhythmias, and even death in patients, which is hampering the market growth.Global Macrolide Antibiotics Market – SegmentsThe report is segmented into five dynamics to widen the scope of understanding,By Drugs : Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, And Telithromycin among others.By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.However, concerns over the adverse effects of macrolide antibiotics such as the gastrointestinal disturbances and adverse hepatic metabolism.
Macrolide antibiotics are also reported to worsen cardiac functioning resulting in tachyarrhythmias, and even death in patients, which is hampering the market growth.Global Macrolide Antibiotics Market – SegmentsThe report is segmented into five dynamics to widen the scope of understanding,By Drugs : Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, And Telithromycin among others.By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023 Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.
By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.However, concerns over the adverse effects of macrolide antibiotics such as the gastrointestinal disturbances and adverse hepatic metabolism.
Macrolide antibiotics are also reported to worsen cardiac functioning resulting in tachyarrhythmias, and even death in patients, which is hampering the market growth.Global Macrolide Antibiotics Market – SegmentsThe report is segmented into five dynamics to widen the scope of understanding,By Drugs : Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, And Telithromycin among others.By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023 Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.
By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.However, concerns over the adverse effects of macrolide antibiotics such as the gastrointestinal disturbances and adverse hepatic metabolism.
Macrolide antibiotics are also reported to worsen cardiac functioning resulting in tachyarrhythmias, and even death in patients, which is hampering the market growth.Global Macrolide Antibiotics Market – SegmentsThe report is segmented into five dynamics to widen the scope of understanding,By Drugs : Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, And Telithromycin among others.By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.However, concerns over the adverse effects of macrolide antibiotics such as the gastrointestinal disturbances and adverse hepatic metabolism.
Macrolide antibiotics are also reported to worsen cardiac functioning resulting in tachyarrhythmias, and even death in patients, which is hampering the market growth.Global Macrolide Antibiotics Market – SegmentsThe report is segmented into five dynamics to widen the scope of understanding,By Drugs : Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, And Telithromycin among others.By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.However, concerns over the adverse effects of macrolide antibiotics such as the gastrointestinal disturbances and adverse hepatic metabolism.
Macrolide antibiotics are also reported to worsen cardiac functioning resulting in tachyarrhythmias, and even death in patients, which is hampering the market growth.Global Macrolide Antibiotics Market – SegmentsThe report is segmented into five dynamics to widen the scope of understanding,By Drugs : Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, And Telithromycin among others.By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
Market HighlightsMacrolides such as azithromycin, clarithromycin, and erythromycin are a class of antibiotics that inhibit protein synthesis.
It acts as a bacteriostatic agent against many strains of corynebacteria, listeria, moxicella, streptococci, Neisseria meningitides, Staphylococci, Clostridia, and Haemophilus sp.
It is used for the treatment of bacterial infections, such as nose, ear, and throat infections, chest infections, skin infections as well as mouth and dental infections.
They are also used as an alternative to penicillin.The global macrolide antibiotics market is expected to show a sharp growth over the forecast period owing to an increasing demand for macrolide across the globe.
Rising prevalence of bacterial skin infections and rising number of dermatology clinics also favor the market growth.
According to a study published in the Journal of the American College of Cardiology, macrolide antibiotics may increase the risk of sudden cardiac death, ventricular tachyarrhythmias, and cardiovascular death in patients, which may hinder the growth of the market over the assessment period.Request For Sample Report:Â https://www.marketresearchfuture.com/sample_request/4342Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023 Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.
By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.However, concerns over the adverse effects of macrolide antibiotics such as the gastrointestinal disturbances and adverse hepatic metabolism.
Macrolide antibiotics are also reported to worsen cardiac functioning resulting in tachyarrhythmias, and even death in patients, which is hampering the market growth.Global Macrolide Antibiotics Market – SegmentsThe report is segmented into five dynamics to widen the scope of understanding,By Drugs : Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, And Telithromycin among others.By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023 Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.
By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.
Macrolide Antibiotics Market Information: By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), By Route of Administration (Oral, Parenteral), By Indication (Infection Due to Mycoplasma Pneumoniae, Legionella Sp, or Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis in Patients with AIDS, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, others), By End User (Hospitals, Dermatology Clinics, Pharmaceutical Companies, others) – Global Forecast till 2023 Macrolide antibiotics consists of deoxy sugars attached to a macrocyclic lactone ring and are members of the polyketide class of antibiotics.
The global macrolide antibiotics market is expected to surge owing to the growing prescription and the growing exposure to pathogens.
The expanding healthcare sector and the growing per capita income are other drivers of the market growth.According to Market Research Future (MRFR), the global macrolide antibiotics market is expected to register a CAGR of over 12.5 % over the assessment period (2017-2023).According to the Centers for Disease Control and Prevention 2017 report, macrolides antibiotic was the second largest prescribed class of antibiotics, resulting in 44.4 million prescriptions while the prescriptions per 1,000 persons rate was 137.
The prescription data also reveals that more than 24.5% prescriptions are dispensed from October to March compared to April to September.
Additional factors that are fostering the market demand include the growing prevalence of skin infections and the expanding healthcare sector especially in the developing world.
By Route of Administration : Oral and Parenteral, among others.By Indication : Mycoplasma Pneumoniae, Legionella Sp, Bordetella Pertussis, Symptomatic Cat-Scratch Disease, Bacillary Angiomatosis, Peliosis Hepatis In Patients With Aids, Cerebral Toxoplasmosis, Uncomplicated Skin Infections, And Others.